Active

C-Biotech

Switched

BE0794909852

Rechtspersoon Private limited company 2 establishments

Frank Van Dyckelaan 15, 9140 Temse Sanering en ander afvalbeheer

Active for

3 year, 8 months

Financials

Financial year 2024

Worth noting

  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Revenue

€ 97,133

▼ 19% vs 2023

Profit

Caution

€ -628,639

▼ 46% vs 2023

Debts

High

€ 2.5 million

▲ 214% vs 2023

C-Biotech from Temse, company number BE0794909852, closed financial year 2024 with a result of € -628,639 after tax. For that financial year C-Biotech recorded revenue of € 97,133 and equity of € 194,724. Compared with financial year 2023, the result moved from € -431,266 to € -628,639. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 27, 2025.

What happened at C-Biotech?

What happened at C-Biotech in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: loss of € 628,639. Source: NBB ↗
  • Bert Weemaes BV became a director. NBB
  • Nova LaGa BV stepped down as director. NBB
  • New establishment in Assesse. KBO
  • New establishment in Temse. KBO
  • Storm, Wolf & Partners CommV. became a director. NBB
  • Nova LaGa BV became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 431,266 loss in 2023 to € 628,639 loss in 2024.

A new publication or filing at C-Biotech? We notify you, reason included.

Follow C-Biotech

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind C-Biotech are Bert Weemaes BV and Storm, Wolf & Partners CommV.. The same people are also behind IMTECH BELGIE, C-Tech Holding, C-LIVING, IMMO MOTCHES and VITA HORECA TEMSE.

See the full network in the app

Directors

According to the 2024 annual accounts

Bert Weemaes BV

Director · represented by Weemaes BERT

Also active at: IMTECH BELGIE, C-Tech Holding, C-LIVING +46 more

since 2025

Storm, Wolf & Partners CommV.

Director · represented by Verstraete FREDERIK

since 2022

Nova LaGa BV

Director · represented by Gacoin LAURENCE

Also active at: C-FIRE, C-LIVING, SOBELTEC +40 more

since 2022 · until 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Frank Van Dyckelaan 15

9140 Temse

2.352.681.451

Rue du Bois-Gilot 2

5336 Assesse

Active since 29 November 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0794.909.852
VAT number
BE 0794.909.852
Registered office
Frank Van Dyckelaan 15, 9140 Temse
Names & denominations
C-Biotech
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
16 December 2022
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Sanering en ander afvalbeheer

Frequently asked questions

What is the enterprise number of C-Biotech?
The enterprise number of C-Biotech is BE0794909852.
What is the address of C-Biotech?
The registered office of C-Biotech is located at Frank Van Dyckelaan 15, 9140 Temse.
When was C-Biotech founded?
C-Biotech was founded on 16 December 2022.
What is the main activity of C-Biotech?
The main activity of C-Biotech is "Sanering en ander afvalbeheer" (NACE code 39000).
Does C-Biotech have a website?
No website is currently known for C-Biotech.
How much profit did C-Biotech make in 2024?
C-Biotech recorded a loss after taxes of € 628,639 in financial year 2024.
What is the revenue of C-Biotech?
In its most recent annual accounts (2024), C-Biotech reported revenue of € 97,133.
How many employees does C-Biotech have?
According to the 2024 annual accounts, C-Biotech has 1.8 full-time equivalents (FTE).
Where can I find the annual accounts of C-Biotech?
C-Biotech files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of C-Biotech?
According to the 2024 annual accounts, the directors of C-Biotech are: Bert Weemaes BV, Storm, Wolf & Partners CommV., Nova LaGa BV.
Who owns C-Biotech?
Behind C-Biotech are Bert Weemaes BV and Storm, Wolf & Partners CommV.. The same people are also behind IMTECH BELGIE, C-Tech Holding, C-LIVING, IMMO MOTCHES and VITA HORECA TEMSE.